Sonoma Pharmaceuticals, Inc. (SNOA) Misses Q4 EPS by 17c

Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) reported Q4 EPS of ($0.29), $0.17 worse than the analyst estimate of ($0.12). Revenue for the quarter came in at $3.4 million versus the consensus estimate of $3.38 million.

For earnings history and earnings-related data on Sonoma Pharmaceuticals, Inc. (SNOA) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• UBS upgrades Lockheed Martin to Buy, sees 26% upside on missile growth
• Mission Produce (AVO) Misses Q3 EPS by 2c; offers outlook